Analysis of the key themes driving M&A activity reveals that robotics accounted for 4 medical devices deals announced in Q2 2023, worth a total value of $1.8bn. The $1.8bn acquisition of Spectrum Plastics Group by DuPont de Nemours was the industry’s largest disclosed deal. GlobalData’s Medical Devices Industry Mergers and Acquisitions Deals by Top Themes in Q2 2023 report helps understand the pivotal themes steering M&A activity in the industry. Buy the report here.
In value terms, robotics-related deal activity decreased by 53% in Q2 2023 compared with the previous quarter’s total of $3.8bn and rose by 9025% as compared to Q2 2022. Related deal volume increased by 300% in Q2 2023 versus the previous quarter and was 100% higher than in Q2 2022.
The top-ranked financial advisors supporting these M&A deals in Q2 2023 were Bank of America; Goldman Sachs Group; Moelis & Co with 1, 1, 1 deals respectively.
The top-ranked legal advisors supporting these M&A deals in Q2 2023 were Cleary Gottlieb Steen & Hamilton; Fried, Frank, Harris, Shriver & Jacobson; Goodwin Procter with 1, 1, 1 deals respectively.
For further understanding of GlobalData's Medical Devices Industry Mergers And Acquisitions Deals By Top Themes In Q2 2023 – Thematic Intelligence, buy the report here.